Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Formula: C10H24N4O4S
CAS Number: 79955-27-4
¹¹]dopentacontan-38-yl]formamido}-3-(4-hydroxyphenyl)propanoic acid
7S)-7-((dimethylamino)methyl)-22
PubMed PMID: 17400802
Pacritinib - CAS# 937272-79-2 Size:Solid 10 mg Formula: C10H24N4O4SPacritinib, also known as SB1518, is a n orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK STAT signaling pathway, and so caspase dependent apoptosis. JAK2 is the most common mutated gene in bcr abl negative myeloproliferative disorders; the JAK2V617F gain of
US$ 2145.00
US$ 3577.50
US$ 5457.48
US$ 2596.12
US$ 9225.00
US$ 6693.00
US$ 5872.50
US$ 20.00
US$ 35.00
US$ 3199.00
US$ 9225.00
US$ 20.00
US$ 4749.50
US$ 35.00
US$ 4293.50
US$ 2068.47
US$ 11383.50
US$ 6549.50